Zevra Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$11.61

-0.23 (-1.94%)

As of Sep 20, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -54.0% upside

Low Target $3.67

Average Target $5.34

High Target $6.76

Current Price $11.61

Current
$11.61

Target
$5.34

$3.67 $5.34 avg $6.76

Scenario Analysis

Bear Case

$3.67

-68.4%

Low target

Base Case

$5.34

-54.0%

Avg target

Bull Case

$6.76

+-41.8%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$15.04

-22.8% from high

52-Week Low

$7.16

+62.2% from low

Target vs 52W High

$5.34

-64.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%